Viewing Study NCT05983250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2026-01-04 @ 6:57 AM
Study NCT ID: NCT05983250
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2023-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Sponsor: Tenax Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HFpEF View
None Pulmonary hypertension group 2 View
None PH-HFpEF View
None Heart Failure View